Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Unknown 2Recruiting 2Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 1787Neoplasms 1504Carcinoma, Non-Small-Cell Lung 1046Prostatic Neoplasms 962Colorectal Neoplasms 881Lung Neoplasms 805Pancreatic Neoplasms 572Carcinoma, Hepatocellular 545Leukemia, Myeloid, Acute 542Stomach Neoplasms 514Ovarian Neoplasms 507Neoplasm Metastasis 501Multiple Myeloma 494Recurrence 412Melanoma 387Squamous Cell Carcinoma of Head and Neck 369Brain Neoplasms 365Uterine Cervical Neoplasms 361Head and Neck Neoplasms 358Esophageal Neoplasms 312Precursor Cell Lymphoblastic Leukemia-Lymphoma 311Lymphoma 306Endometrial Neoplasms 304Triple Negative Breast Neoplasms 301Glioblastoma 300Rectal Neoplasms 284Sarcoma 267Urinary Bladder Neoplasms 266Hematologic Neoplasms 265Colonic Neoplasms 255

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Safety Issues × Clear all
NCT05142592 2025-09-24

Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors

Nanjing Immunophage Biotech Co., Ltd

Phase 1/2 Recruiting
196 enrolled

Safety Issues

NCT06509490 2024-07-19

NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase NA Recruiting
9 enrolled

Safety Issues

Data powered by HemOnc (CC BY 4.0) Colophon âš¡